Location: Dallas, TX
CIK: 0001791827 · Show all filings
Period: Q3 2023 (← Previous) (Next →)
Filing Date: Nov 14, 2023
Total Value: $2.483B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BSX | BOSTON SCIENTIFIC CORP | 2,065,800 | $109M | 4.4% | $48.57 | +8.0% | COM | 101137107 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 797,500 | $103M | 4.2% | $146.78 | -9.2% | SHS USD | G50871105 |
| BDX | BECTON DICKINSON & CO | 286,800 | $74.15M | 3.0% | $234.92 | +9.9% | COM | 075887109 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 652,100 | $73.36M | 3.0% | $96.63 | +9.0% | COM | 64125C109 |
| MCK | MCKESSON CORP | 166,300 | $72.32M | 2.9% | $394.09 | +5.7% | COM | 58155Q103 |
| LEGN | LEGEND BIOTECH CORP | 967,000 | $64.95M | 2.6% | $52.73 | — | SPONSORED ADS | 52490G102 |
| THC | TENET HEALTHCARE CORP | 963,800 | $63.5M | 2.6% | $51.02 | +46.5% | COM NEW | 88033G407 |
| CI | THE CIGNA GROUP | 207,700 | $59.42M | 2.4% | $272.79 | 0.0% | COM | 125523100 |
| IDYA | IDEAYA BIOSCIENCES INC | 2,144,971 | $57.87M | 2.3% | $17.94 | +41.4% | COM | 45166A102 |
| UNH | UNITEDHEALTH GROUP INC | 112,200 | $56.57M | 2.3% | $469.94 | 0.0% | COM | 91324P102 |
| SRPT | SAREPTA THERAPEUTICS INC | 450,000 | $54.55M | 2.2% | $105.95 | +6.7% | COM | 803607100 |
| HUM | HUMANA INC | 110,300 | $53.66M | 2.2% | $456.59 | 0.0% | COM | 444859102 |
| ARVN | ARVINAS INC | 2,614,960 | $51.36M | 2.1% | $51.25 | -52.1% | COM | 04335A105 |
| ACHC | ACADIA HEALTHCARE COMPANY IN | 715,000 | $50.27M | 2.0% | $72.90 | +2.5% | COM | 00404A109 |
| — | KARUNA THERAPEUTICS INC | 286,700 | $48.48M | 2.0% | $182.44 | — | COM | 48576A100 |
| REGN | REGENERON PHARMACEUTICALS | 58,000 | $47.73M | 1.9% | $768.10 | +1.8% | COM | 75886F107 |
| ZTS | ZOETIS INC | 262,100 | $45.6M | 1.8% | $162.10 | +9.1% | CL A | 98978V103 |
| IMVT | IMMUNOVANT INC | 1,173,662 | $45.06M | 1.8% | $18.00 | +25.6% | COM | 45258J102 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 777,172 | $44.3M | 1.8% | $40.64 | +35.8% | CLASS A ORD | 61559X104 |
| DHR | DANAHER CORPORATION | 176,600 | $43.81M | 1.8% | $220.19 | 0.0% | COM | 235851102 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 2,100,000 | $42.13M | 1.7% | $40.26 | -37.0% | COM | 98943L107 |
| — | INTRA-CELLULAR THERAPIES INC | 801,100 | $41.73M | 1.7% | $52.09 | — | COM | 46116X101 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 2,821,000 | $40.96M | 1.6% | $18.43 | +2.6% | COM | 87164F105 |
| LLY | ELI LILLY & CO | 75,000 | $40.28M | 1.6% | $411.47 | +23.2% | COM | 532457108 |
| NTRA | NATERA INC | 899,000 | $39.78M | 1.6% | $56.20 | -9.2% | COM | 632307104 |
| ARGX | ARGENX SE | 80,600 | $39.63M | 1.6% | $363.49 | — | SPONSORED ADR | 04016X101 |
| SGRY | SURGERY PARTNERS INC | 1,338,000 | $39.14M | 1.6% | $27.35 | +31.4% | COM | 86881A100 |
| LNTH | LANTHEUS HLDGS INC | 558,400 | $38.8M | 1.6% | $80.43 | -9.1% | COM | 516544103 |
| PCVX | VAXCYTE INC | 756,165 | $38.55M | 1.6% | $39.49 | +24.9% | COM | 92243G108 |
| — | BLUEPRINT MEDICINES CORP | 751,600 | $37.75M | 1.5% | $57.39 | — | COM | 09627Y109 |
| — | AKERO THERAPEUTICS INC | 739,100 | $37.38M | 1.5% | $37.86 | — | COM | 00973Y108 |
| MIRM | MIRUM PHARMACEUTICALS INC | 1,142,850 | $36.11M | 1.5% | $27.38 | 0.0% | COM | 604749101 |
| PRVA | PRIVIA HEALTH GROUP INC | 1,545,100 | $35.54M | 1.4% | $26.12 | -2.6% | COM | 74276R102 |
| DXCM | DEXCOM INC | 377,700 | $35.24M | 1.4% | $112.73 | 0.0% | COM | 252131107 |
| BHVN | BIOHAVEN LTD | 1,285,400 | $33.43M | 1.3% | $14.12 | +47.2% | COM | G1110E107 |
| RCKT | ROCKET PHARMACEUTICALS INC | 1,587,429 | $32.53M | 1.3% | $18.47 | -1.6% | COM | 77313F106 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 1,756,940 | $32.17M | 1.3% | $28.12 | -24.8% | COM | 03237H101 |
| — | IMMUNOGEN INC | 1,917,907 | $30.44M | 1.2% | $18.87 | — | COM | 45253H101 |
| BIIB | BIOGEN INC | 115,400 | $29.66M | 1.2% | $282.19 | -5.2% | COM | 09062X103 |
| CRBU | CARIBOU BIOSCIENCES INC | 6,050,212 | $28.92M | 1.2% | $13.29 | -53.3% | COM | 142038108 |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 1,063,897 | $28.59M | 1.2% | $46.85 | -34.6% | COM | 04280A100 |
| HCA | HCA HEALTHCARE INC | 114,800 | $28.24M | 1.1% | $268.37 | 0.0% | COM | 40412C101 |
| NMRA | NEUMORA THERAPEUTICS INC. | 1,800,000 | $25.4M | 1.0% | $12.87 | 0.0% | COM | 640979100 |
| GPCR | STRUCTURE THERAPEUTICS INC | 500,000 | $25.21M | 1.0% | $49.75 | — | SPONSORED ADS | 86366E106 |
| UHS | UNIVERSAL HLTH SVCS INC | 182,000 | $22.88M | 0.9% | $116.28 | +16.1% | CL B | 913903100 |
| — | CUREVAC N V | 3,116,100 | $21.28M | 0.9% | $7.57 | — | COM | N2451R105 |
| AXSM | AXSOME THERAPEUTICS INC | 296,800 | $20.74M | 0.8% | $49.97 | +49.6% | COM | 05464T104 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 544,000 | $19.39M | 0.8% | $59.10 | -33.0% | COM | 90400D108 |
| PRTA | PROTHENA CORP PLC | 382,305 | $18.45M | 0.7% | $40.61 | +46.3% | SHS | G72800108 |
| RVMD | REVOLUTION MEDICINES INC | 657,200 | $18.19M | 0.7% | $20.59 | +44.1% | COM | 76155X100 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 610,000 | $18.14M | 0.7% | $20.61 | 0.0% | COM | 22663K107 |
| IMCR | IMMUNOCORE HLDGS PLC | 348,200 | $18.07M | 0.7% | $41.38 | — | ADS | 45258D105 |
| ROIV | ROIVANT SCIENCES LTD | 1,503,302 | $17.56M | 0.7% | $8.94 | +26.4% | SHS | G76279101 |
| ANTX | AN2 THERAPEUTICS INC | 1,089,400 | $17.52M | 0.7% | $13.49 | -16.1% | COM | 037326105 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 1,617,300 | $16.77M | 0.7% | $22.29 | -38.5% | COM | 71722W107 |
| DNTH | DIANTHUS THERAPEUTICS INC | 1,217,554 | $16.64M | 0.7% | $12.62 | 0.0% | COM | 252828108 |
| — | FUSION PHARMACEUTICALS INC | 5,781,850 | $15.03M | 0.6% | $3.75 | — | COM | 36118A100 |
| — | CEREVEL THERAPEUTICS HLDNG I | 643,000 | $14.04M | 0.6% | $29.59 | — | COM | 15678U128 |
| — | VERONA PHARMA PLC | 830,300 | $13.53M | 0.5% | $20.16 | — | SPONSORED ADS | 925050106 |
| VTYX | VENTYX BIOSCIENCES INC | 354,900 | $12.33M | 0.5% | $32.67 | +5.8% | COM | 92332V107 |
| NTLA | INTELLIA THERAPEUTICS INC | 379,100 | $11.99M | 0.5% | $62.55 | -38.0% | COM | 45826J105 |
| TVTX | TRAVERE THERAPEUTICS INC | 1,323,000 | $11.83M | 0.5% | $14.11 | 0.0% | COM | 89422G107 |
| SDGR | SCHRODINGER INC | 399,000 | $11.28M | 0.5% | $35.81 | +12.5% | COM | 80810D103 |
| — | KARYOPHARM THERAPEUTICS INC | 8,298,570 | $11.12M | 0.4% | $3.40 | — | COM | 48576U106 |
| — | RAYZEBIO INC | 500,000 | $11.1M | 0.4% | $22.20 | — | COM | 75525N107 |
| XENE | XENON PHARMACEUTICALS INC | 321,400 | $10.98M | 0.4% | $39.75 | -5.9% | COM | 98420N105 |
| PACB | PACIFIC BIOSCIENCES CALIF IN | 1,034,294 | $8.636M | 0.3% | $10.21 | +11.9% | COM | 69404D108 |
| ACIU | AC IMMUNE SA | 2,969,800 | $8.464M | 0.3% | $2.30 | +32.5% | SHS | H00263105 |
| COLL | COLLEGIUM PHARMACEUTICAL INC | 350,200 | $7.827M | 0.3% | $25.89 | -11.9% | COM | 19459J104 |
| — | ALPINE IMMUNE SCIENCES INC | 657,280 | $7.526M | 0.3% | $10.23 | — | COM | 02083G100 |
| — | KEZAR LIFE SCIENCES INC | 6,011,100 | $7.153M | 0.3% | $12.16 | — | COM | 49372L100 |
| SYRS | SYROS PHARMACEUTICALS INC | 1,581,142 | $6.246M | 0.3% | $6.06 | -38.3% | COM NEW | 87184Q206 |
| — | GRITSTONE BIO INC | 2,733,800 | $4.702M | 0.2% | $1.95 | — | COM | 39868T105 |
| ATEC | ALPHATEC HLDGS INC | 309,400 | $4.013M | 0.2% | $15.57 | +0.6% | COM NEW | 02081G201 |
| — | NANOSTRING TECHNOLOGIES INC | 2,299,100 | $3.954M | 0.2% | $8.62 | — | COM | 63009R109 |
| — | VERVE THERAPEUTICS INC | 285,334 | $3.784M | 0.2% | $29.34 | — | COM | 92539P101 |
| CMPX | COMPASS THERAPEUTICS INC | 1,599,600 | $3.151M | 0.1% | $3.29 | -24.8% | COM | 20454B104 |
| ALT | ALTIMMUNE INC | 1,159,900 | $3.016M | 0.1% | $11.39 | -74.8% | COM NEW | 02155H200 |
| SCYX | SCYNEXIS INC | 1,319,444 | $3.008M | 0.1% | $2.92 | +2.3% | COM NEW | 811292200 |
| HYPR | HYPERFINE INC | 1,188,178 | $2.436M | 0.1% | $9.78 | -76.4% | COM CL A | 44916K106 |
| IPSC | CENTURY THERAPEUTICS INC | 1,098,500 | $2.197M | 0.1% | $19.69 | -86.5% | COM | 15673T100 |
| — | CAREMAX INC | 636,000 | $1.348M | 0.1% | $12.86 | — | COM CL A | 14171W103 |
| — | NUVATION BIO INC | 89,543 | $8,954 | 0.0% | $2.67 | — | *W EXP 07/07/202 | 67080N119 |